Home > Publications > SATVI Research Papers Published

SATVI Research Papers Published

Since its establishment in 2001, the South African Tuberculosis Vaccine Initiative (SATVI) has produced many high impact articles, documenting research findings in international journals and made presentations at a range of international conferences.

View the complete SATVI Bibiography on Pub Med . Click here.

2017-Publications published by SATVI authors in Peer-reviewed Journals during 2017
Date Title Authors Journal
15 January 2017 Safety and Immunogenicity of Adenovirus 35 TB Vaccine Candidate in Adults with Active or Previous TB: a Randomized Trial van Zyl-Smit R; Esmail A; Bateman M; Dawson R; Goldin J; Rikxoort J; Douoguih M; Grazia Pau M; Sadoff JC; McClain JB; Snowden MA; Benko J; Hokey DA; Tucker Rutkowski K; Graves A; Shepherd B; Ishmukhamedov S; Kagina B; Abel B; Hanekom WA; Scriba TJ; Bateman ED American Journal of Respiratory and Critical Care Medicine
15 January 2017 A novel blood test for tuberculosis prevention and treatment  A Penn-Nicholson, T J Scriba, M Hatherill, R G White, T Sumner South African Medical Journal
2016-Publications published by SATVI authors in Peer-reviewed Journals during 2016
Date Published Title Authors Journal
November Teaching advanced flow cytometry in Africa: 10 years of lessons learned. Nemes E, Burgers WA, Riou C, Andersen-Nissen E, Ferrari G, Gray CM, Scriba T. Cytometry.Part A: Journal of the International Society for Analytical Cytology.
November 2016 Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis Petruccioli E, Scriba T, Petrone L, Hatherill M, Cirillo D, Joosten S, Ottenhoff T, Denkinger C, Goletti D. European Respiratory Journal
October 2016 Human Immunology of Tuberculosis. Scriba TJ, Coussens AK, Fletcher HA.  Microbiology Spectrum
October 2016 Vaccination Against Tuberculosis With Whole-Cell Mycobacterial Vaccines. Scriba TJ, Kaufmann SH, Henri Lambert P, Sanicas M, Martin C, Neyrolles O. The Journal of Infectious Diseases. 
August 2016 Bacillus Calmette–Guerin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses Suliman S, Geldenhuys H, Johnson J, Hughes J, Smit E, Murphy M, Toefy A, Lerumo L, Hopley C, Pienaar B, Chheng P, Nemes E, Hoft D, Hanekom W, Boom WH, Hatherill M, Scriba TJ. Journal of  Immunology
August 2016 Epidemiologic studies and novel clinical research approaches that impact TB vaccine development. Evans TG, Churchyard GJ, Penn-Nicholson A, Chen C, Gao X, Tait DR, Hatherill M. Tuberculosis (Edinburgh, Scotland).
July 2016 A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans. Lindestam Arlehamn CS, McKinney DM, Carpenter C, Paul S, Rozot V, Makgotlho E, Gregg Y, van Rooyen M, Ernst JD, Hatherill M, Hanekom WA, Peters B, Scriba TJ, Sette A. PLoS Pathogens
June 2016 A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Zak D, Penn-Nicholson A, Scriba TJ, Thompson E, Suliman S, Amon L, Mahomed H, Erasmus M, Whatney W, Hussey GD, Abrahams D, Kafaar F, Hawkridge T, Verver S, Hughes EJ, Ota M, Sutherland J, Howe R, Dockrell H, Boom WH, Thiel B, Ottenhoff T, Mayanja-Kizza H, Crampin A, Downing K, Hatherill M, Valvo J, Shankar S, Shreemanta K Parida, Kaufmann S, Walzl G, Aderem A, Hanekom WA, for the ACS and GC6-74 cohort study groups. Lancet
June 2016 A Glucuronoxylomannan-Associated Immune Signature, Characterized by Monocyte Deactivation and an Increased Interleukin 10 Level, Is a Predictor of Death in Cryptococcal Meningitis. Scriven JE, Graham LM, Schutz C, Scriba TJ, Wilkinson KA, Wilkinson RJ, Boulware DR, Urban BC, Lalloo DG, Meintjes G. J Infect Dis.
May 2016 Human newborn bacille Calmette-Guérin vaccination and risk of tuberculosis disease: a case-control study. Fletcher H, Filali-Mouhim A, Nemes E, Hawkridge A, Keyser A, Njikan S, Hatherill M, Scriba TJ, Abel B, Kagina BM, Veldsman A, Agudelo NM, Kaplan G, Hussey GD, Sekaly RP, Hanekom WA; BCG study team. BMC Med
May 2016 BCG and New Preventive Tuberculosis Vaccines: Implications for Healthcare Workers. Hatherill M, Scriba TJ, Udwadia ZF, Mullerpattan JB, Hawkridge A, Mahomed H, Dye C. Clinical Infectious Disease
April 2016 T-cell activation is an immune correlate of risk in BCG vaccinated infants Fletcher H, Snowden M, Landry B, Rida W, Satti I, Harris S, Matsumiya M, Tanner R, O’Shea M, Dheenadhayalan V, Bogardus L, Stockdale L, Marsay L, Chomka A, Harrington-Kandt R, Manjaly-Thomas ZR, Naranbhai V, Stylianou E, Darboe F, Penn-Nicholson A, Nemes E, Hatherill M, Hussey G, Mahomed H, Tameris M, McClain J, Evans TG, Hanekom W, Scriba TJ, & McShane H. Nature
April 2016 Engaging adolescents in tuberculosis and clinical trial research through drama Schmidt B, Abrams A & Tameris M. Trials
March 2016 Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review. McShane H, Hatherill M, Hanekom W, Evans T. Int J Epidemiol.
January 2016 Flow Cytometry To Assess Cerebrospinal Fluid Fungal Burden in Cryptococcal Meningitis. Scriven JE, Graham LM, Schutz C, Scriba TJ, Wilkinson RJ, Boulware DR, Meintjes G, Lalloo DG, Urban BC. J Clin Microbiol.
January 2016 Real-Time Investigation of Tuberculosis Transmission: Developing the Respiratory Aerosol Sampling Chamber (RASC). Wood R, Morrow C, Barry CE 3rd, Bryden WA, Call CJ, Hickey AJ, Rodes CE, Scriba TJ, Blackburn J, Issarow C, Mulder N, Woodward J, Moosa A, Singh V, Mizrahi V, Warner DF. PLoS One.
January 2016 Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status. Rhodes SJ, Knight GM, Fielding K, Scriba TJ, Pathan AA, McShane H, Fletcher H, White RG. Tuberculosis (Edinb).